ALGORITM DIAGNOSTIKI I VEDENIYa ZhENShchIN S SINDROMOM POLIKISTOZNYKh YaIChNIKOV V RANNEM REPRODUKTIVNOM VOZRASTE


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Full Text

Restricted Access

References

  1. Teede H.J., Misso M.L., Costello M.F., Dokras A., Laven J. et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil. Steril. 2018; 110 (3): 364-79. https://dx.doi.org/10.1016/j.fertnstert.2018.05.004.
  2. Fauser B.C.J.M. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril. Elsevier Inc. 2004; 81(1): 19-25.
  3. Misso M. et al. International evidence-based guideline for the assessment and management of polycystic ovary syndrome 2018. National Health and Medical Research Council (NHMRC) on. 2018; 2.
  4. Lizneva D, Suturina L, Walker W., Brakta S., Gavrilova-Jordan L. et al. Criteria, prevalence, and phenotypes of polycystic ovary syndrome. Fertil. Steril. 2016; 106 (1): 6-15. https://dx.doi.org/10.1016/j.fertnstert.2016.05.003.
  5. Kamenov Z., Gateva A. Inositols in PCOS. Molecules. 2020; 25(23): 5566. https://dx.doi.org/10.3390/molecules25235566.
  6. Lagana A.S., Rossetti P., Buscema M, La Vignera S., Condorelli R.A., Gullo G., Granese R., Triolo O. Metabolism and Ovarian Function in PCOS Women: A Therapeutic Approach with Inositols. Int J Endocrinol. 2016; 2016: 6306410. https://dx.doi.org/10.1155/2016/6306410.
  7. Lagana A.S., Garzon S., Casarin J., Franchi M., Ghezzi F. Inositol in Polycystic Ovary Syndrome: Restoring Fertility through a Pathophysiology-Based Approach. Trends Endocrinol Metab. 2018; 29(11): 768-80. https://dx.doi.org/10.1016/j.tem.2018.09.001.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies